NovoCure Aktie
WKN DE: A140ML / ISIN: JE00BYSS4X48
|
30.10.2025 13:53:13
|
Novocure Posts Wider Loss In Q3
(RTTNews) - Novocure (NVCR) reported a third quarter net loss of $37.3 million compared to a loss of $30.6 million, prior year. Net loss per ordinary share was $0.33 compared to a loss of $0.28. Analysts on average expected the company to report a loss per share of $0.42, for the quarter. Analysts' estimates typically exclude special items.
Total net revenues for the quarter were $167.2 million, an increase of 8% compared to the same period in 2024. The company said this increase was primarily driven by active patient growth, as well as $3.3 million in exchange rate benefits.
Shares of Novocure are up 7% in pre-market trade on Thursday.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NovoCure Limitedmehr Nachrichten
|
15.10.25 |
Erste Schätzungen: NovoCure legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
|
09.07.25 |
Erste Schätzungen: NovoCure stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu NovoCure Limitedmehr Analysen
Aktien in diesem Artikel
| NovoCure Limited | 11,08 | -3,99% |
|